HWM
REGN icon

Hemington Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Hemington Wealth Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$52K Buy
94
+5
+6% +$2.83K 0.01% 353
2025
Q2 		$46K Sell
89
-36
-29% -$20.1K 0.01% 355
2025
Q1 		$79K Buy
125
+4
+3% +$2.75K 0.01% 243
2024
Q4 		$86K Buy
121
+27
+29% +$22.7K 0.02% 215
2024
Q3 		$78K Buy
+94
New +$105K 0.02% 224

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Hemington Wealth Management's REGN Position: Q3 2025 in Review

Hemington Wealth Management increased its Regeneron Pharmaceuticals (REGN) stake by 5.6% in Q3 2025, buying an estimated $2.83K and bringing the position to 94 shares worth $52K. The position accounts for 0.01% of the portfolio, ranked #353.

Hemington Wealth Management first reported a position in REGN in Q3 2024 and has held it in 5 quarters since. The position peaked at $86K in Q4 2024. 1,244 funds tracked by Wall St. Rank hold REGN as of Q3 2025.

  • Hemington Wealth Management held 94 shares of Regeneron Pharmaceuticals worth $52K as of Q3 2025.
  • Hemington Wealth Management bought 5 Regeneron Pharmaceuticals shares in Q3 2025, an estimated $2.83K.
  • Regeneron Pharmaceuticals made up 0.01% of Hemington Wealth Management's portfolio in Q3 2025, its #353 holding.
  • Hemington Wealth Management first reported a position in Regeneron Pharmaceuticals in Q3 2024 and has held it in 5 quarters since.
  • Hemington Wealth Management's Regeneron Pharmaceuticals position peaked at $86K in Q4 2024.
  • 1,244 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2025.

Based on Hemington Wealth Management's 13F filing for Q3 2025, filed 24 Oct 2025.